Sort
78,016 grants matching “breast cancer”
Metallo-fluorocarbon nanoemulsion for PET detection of cancer inflammation
$622,917Eric T Ahrens · University Of California, San Diego · R01 · FY2024 · CA
CCR FACS Core Laboratory
$622,887Barbara Taylor · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes
$622,843Mark H Greene · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
The Role of Carboxypeptidase E in Cancer
$622,816Yoke P Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
DREAM: Discovering cancer Risks from Environmental contaminants And Maternal/child health
$622,811Peggy Reynolds · University Of California, San Francisco · UG3 · FY2024 · CA
Promoting Breast Cancer Screening in Non-Adherent Women
$622,786Roger S Luckmann · Univ Of Massachusetts Med Sch Worcester · R01 · FY2012 · CA
EMPOWER Study: Promoting BC Screening in Women Who Survived Childhood Cancer
$622,780Kevin Charles Oeffinger · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Endoscopic Fine-Needle Light Scattering Spectroscopy for Pancreatic Cyst Diagnosis and Evaluation of Malignant Potential
$622,771Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2025 · EB
Choreography of Eukaryotic DNA Replication
$622,722Bonita J Brewer · University Of Washington · R35 · FY2017 · GM
A premalignant chronology of cell-state variability in basal-like breast cancer
$622,712Kevin A Janes · University Of Virginia · R01 · FY2024 · CA
Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci
$622,687Simon Andrew Gayther · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Novel Role of ThPOK in Mammary Carcinoma
$622,664Dietmar J Kappes · Research Inst Of Fox Chase Can Ctr · R01 · FY2022 · CA
Novel Role of ThPOK in Mammary Carcinoma
$622,664Dietmar J Kappes · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · CA
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer
$622,570Joanna E Burdette · University Of Illinois At Chicago · R01 · FY2024 · CA
Mitochondrial iron export therapy for doxorubicin-induced cardiotoxicity
$622,565Jonghan Kim · University Of Massachusetts Lowell · R01 · FY2024 · HL
Collaborative Research and Action: Empowering an Exposed Community
$622,501Michele Marcus · Emory University · R01 · FY2019 · ES
Consortium Study to Identify Breast Cancer Susceptibility Loci
$622,479Wei Zheng · Vanderbilt University · R01 · FY2014 · CA
UBR5's mechanisms of action in tumorigenesis and immunoregulation
$622,468Xiaojing Ma · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Dynamic Imaging of EMT in the Breast Cancer Microenvironment
$622,396Christopher H Contag · Stanford University · R01 · FY2014 · CA
Couple Communication Skills Training for Advanced Cancer
$622,336Laura S Porter · Duke University · R01 · FY2020 · CA
Modulating growth, progression and metastasis in breast cancer by inhibiting MDA-9
$622,329Paul B Fisher · Virginia Commonwealth University · R01 · FY2024 · CA
Prognostic analysis and progression modeling of basal-like breast cancer using multi-region sequencing
$622,328Yijun Sun · State University Of New York At Buffalo · R01 · FY2025 · CA
Mayo Clinic SPORE in Ovarian Cancer
$622,294Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2014 · CA
Genome-wide Copy Number Variation and Breast Cancer Risk
$622,281Jirong Long · Vanderbilt University · R01 · FY2010 · CA
Radiomic phenotypes of breast parenchyma and association with breast cancer risk and detection
$622,266Celine M Vachon · Mayo Clinic Rochester · R01 · FY2021 · CA